X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1416) 1416
Book Review (360) 360
Publication (69) 69
Book Chapter (27) 27
Dissertation (14) 14
Conference Proceeding (8) 8
Magazine Article (3) 3
Paper (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fibrates (965) 965
index medicus (788) 788
humans (650) 650
statins (463) 463
fibrate (362) 362
male (298) 298
pharmacology & pharmacy (255) 255
animals (243) 243
hypolipidemic agents - therapeutic use (232) 232
female (217) 217
cholesterol (206) 206
middle aged (191) 191
coronary-heart-disease (181) 181
atherosclerosis (165) 165
dyslipidemia (160) 160
risk factors (159) 159
triglycerides (157) 157
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (153) 153
statin (147) 147
biochemistry & molecular biology (139) 139
metabolic syndrome (138) 138
niacin (138) 138
cardiac & cardiovascular systems (136) 136
lipids (136) 136
fenofibrate (133) 133
hypolipidemic agents - pharmacology (132) 132
ezetimibe (123) 123
diabetes (122) 122
aged (119) 119
dyslipidemias - drug therapy (113) 113
peripheral vascular disease (113) 113
cardiovascular disease (111) 111
type-2 diabetes-mellitus (109) 109
drug therapy, combination (108) 108
gemfibrozil (108) 108
adult (107) 107
endocrinology & metabolism (105) 105
treatment outcome (99) 99
mice (96) 96
cardiovascular-disease (94) 94
secondary prevention (93) 93
density-lipoprotein cholesterol (91) 91
triglycerides - blood (90) 90
cardiovascular diseases - prevention & control (88) 88
fenofibrate - therapeutic use (87) 87
fenofibrate - pharmacology (86) 86
ppar-alpha (85) 85
hypolipidemic agents - adverse effects (83) 83
cholesterol, hdl - blood (82) 82
hypertriglyceridemia (78) 78
risk (77) 77
hyperlipidemias - drug therapy (75) 75
therapy (74) 74
metabolism (72) 72
type 2 diabetes (72) 72
myocardial-infarction (71) 71
cholesterol, ldl - blood (70) 70
inflammation (68) 68
rats (68) 68
fibric acids (67) 67
hyperlipidemia (67) 67
medicine, general & internal (67) 67
c-reactive protein (65) 65
cardiovascular risk (64) 64
fibric acids - therapeutic use (64) 64
low density lipoproteins (64) 64
coronary heart disease (63) 63
prevention (63) 63
coronary-artery-disease (62) 62
expression (62) 62
lipids - blood (62) 62
lipoproteins (62) 62
nicotinic acid (62) 62
high-density-lipoprotein (61) 61
ppar (61) 61
cardiovascular (60) 60
cardiovascular diseases (60) 60
hypercholesterolemia (60) 60
rhabdomyolysis (60) 60
anticholesteremic agents - therapeutic use (59) 59
gene-expression (59) 59
medicine & public health (59) 59
randomized controlled-trial (59) 59
insulin resistance (58) 58
insulin-resistance (58) 58
risk-factors (58) 58
simvastatin (58) 58
atorvastatin (57) 57
clofibric acid - therapeutic use (57) 57
bezafibrate (56) 56
diabetes mellitus, type 2 - drug therapy (55) 55
low-density-lipoprotein (54) 54
hdl-cholesterol (53) 53
disease (52) 52
liver (52) 52
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (51) 51
ppar alpha - agonists (51) 51
research (51) 51
triglyceride (50) 50
diabetes mellitus (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1205) 1205
French (97) 97
Czech (37) 37
Spanish (35) 35
German (30) 30
Portuguese (14) 14
Polish (13) 13
Japanese (7) 7
Korean (5) 5
Chinese (4) 4
Hungarian (4) 4
Russian (3) 3
Slovak (3) 3
Croatian (2) 2
Italian (2) 2
Slovenian (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Pharmacotherapy, ISSN 1060-0280, 10/2011, Volume 45, Issue 10, pp. 1230 - 1239
Journal Article
Clinical Science, ISSN 0143-5221, 04/2016, Volume 130, Issue 8, pp. 625 - 641
Fenofibrate (FF), as a peroxisome-proliferator-activated receptor alpha (PPAR alpha) agonist, has been used clinically for decades to lower lipid levels. In... 
Diabetic cardiomyopathy | FGF21-knockout | Sirt1 | PPARα agonist (fibrate) | Autophagy | MEDICINE, RESEARCH & EXPERIMENTAL | ADIPOSE TRIGLYCERIDE LIPASE | PPAR-ALPHA | OXIDATIVE STRESS | autophagy | ALPHA ACTIVATOR FENOFIBRATE | PPARa agonist (fibrate) | CARDIOMYOPATHY | diabetic cardiomyopathy | RANDOMIZED CONTROLLED-TRIAL | MOUSE MODELS | LIPID-ACCUMULATION | ENDOTHELIAL-CELLS | GROWTH-FACTOR 21 | Sirtuin 1 - metabolism | Diabetes Mellitus, Experimental - drug therapy | Hypertrophy, Left Ventricular - enzymology | Myocarditis - etiology | Diabetic Cardiomyopathies - etiology | Diabetes Mellitus, Experimental - enzymology | Fibroblast Growth Factors - genetics | Myocarditis - enzymology | Male | Diabetes Mellitus, Type 1 - complications | Diabetic Cardiomyopathies - physiopathology | Autophagy - drug effects | Fibroblast Growth Factors - metabolism | Fenofibrate - pharmacology | Time Factors | Hypertrophy, Left Ventricular - pathology | Myocarditis - prevention & control | Diabetic Cardiomyopathies - prevention & control | Diabetes Mellitus, Experimental - complications | Diabetic Cardiomyopathies - enzymology | Diabetes Mellitus, Type 1 - enzymology | Cell Line | Hypertrophy, Left Ventricular - prevention & control | Mice, Inbred C57BL | Ventricular Function, Left - drug effects | Diabetes Mellitus, Type 1 - pathology | Rats | Myocardium - pathology | Fibroblast Growth Factors - deficiency | Diabetes Mellitus, Type 1 - drug therapy | Mice, Knockout | Myocardium - enzymology | Animals | Signal Transduction - drug effects | Fibrosis | Diabetes Mellitus, Experimental - pathology | Diabetic Cardiomyopathies - pathology | Histone Deacetylase Inhibitors - pharmacology | Myocarditis - pathology | Oxidative Stress - drug effects | Blood Glucose - metabolism | Myocarditis - physiopathology | Ventricular Remodeling - drug effects | Index Medicus
Journal Article
Journal of Atherosclerosis and Thrombosis, ISSN 1340-3478, 2018
Aim: To verify the superiority of pemafibrate over placebo and the non-inferiority of pemafibrate to the maximum dose of fenofibrate for determining the... 
Selective PPARα modulator | Fibrate | Residual risk | Triglycerides | Safety
Journal Article
Yakugaku Zasshi, ISSN 0031-6903, 04/2016, Volume 136, Issue 4, pp. 579 - 582
Journal Article
International journal of organic chemistry, ISSN 2161-4687, 06/2018, Volume 8, Issue 2, pp. 201 - 206
Practical synthetic route for the formation of enantiomeric mixture of Isopropyl 2-(4-((4-chlorophenyl)(hydroxyl)methyl)phenoxy)-2-methylpropanoate (Fibratol... 
Reduction | Fibrate | Chirality | Optical Activity
Journal Article
Pharmacological Research, ISSN 1043-6618, 09/2019, Volume 147, pp. 104362 - 104362
Lysosomal acid lipase (LAL) is responsible for the hydrolysis of cholesteryl esters (CE) and triglycerides (TG) within the lysosomes; generated cholesterol and... 
Lysosomal acid lipase | Fibrates | Statins | Dyslipidemia | Index Medicus
Journal Article
Journal Article
Annals of Hepatology, ISSN 1665-2681, 09/2017, Volume 16, Issue 5, pp. 704 - 706
Journal Article
Journal Article
Orvosi Hetilap, ISSN 0030-6002, 05/2016, Volume 157, Issue 19, pp. 746 - 752
Journal Article
Experimental and Clinical Endocrinology and Diabetes, ISSN 0947-7349, 05/2018, Volume 126, Issue 5, pp. 321 - 326
Levothyroxine and selenomethionine were found to reduce thyroid antibody titers in patients with Hashimoto's thyroiditis. The same effect was produced by... 
fibrates | levothyroxine | thyroiditis | hypothalamic-pituitary-thyroid axis | statins | Index Medicus
Journal Article
Gastroenterology and Hepatology, ISSN 1554-7914, 03/2018, Volume 14, Issue 3, pp. 154 - 163
Primary biliary cholangitis (PBC) is an autoimmune inflammatory liver disease of the interlobular bile ducts that can lead to cirrhosis and liver failure.... 
Farnesoid X receptor | FGF19 analog | Primary biliary cholangitis | Therapy | Fibrate | Peroxisome proliferator-activated receptor agonist | Column | farnesoid X receptor | therapy | peroxisome proliferator-activated receptor agonist | fibrate
Journal Article
Revue medicale de Liege, ISSN 0370-629X, 03/2019, Volume 74, Issue 3, pp. 167 - 172
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 09/2010, Volume 26, Issue 9, pp. 2141 - 2146
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 09/2019, Volume 59, Issue 9, pp. 1170 - 1176
This large‐scale case‐control study in Taiwan elucidated the potential connection between fibrate use and liver cancer by using the Longitudinal Health... 
lipid‐lowering | anticancer drug | cancer | liver cancer | fibrate | PPAR-ALPHA | RISK-FACTORS | FENOFIBRATE | PROLIFERATION | ACTIVATED-RECEPTOR-ALPHA | HEPATOCELLULAR-CARCINOMA | lipid-lowering | METABOLISM | LIGANDS | GROWTH | PHARMACOLOGY & PHARMACY | HEPATITIS-B | Liver cancer | Population (statistical) | Statistical analysis | Liver | Population studies | Regression analysis | Cancer | Index Medicus
Journal Article